ALPHAGAN P (Allergan, Inc.)
Welcome to the PulseAid listing for the ALPHAGAN P drug offered from Allergan, Inc.. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | brimonidine tartrate |
| SUBSTANCE NAME: | BRIMONIDINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2001-07-10 |
| END MARKETING DATE: | 0000-00-00 |
ALPHAGAN P HUMAN PRESCRIPTION DRUG Details:
| Item Description | ALPHAGAN P from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/mL) |
| START MARKETING DATE: | 2001-07-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-9177_5aef5742-0096-4aee-ab72-1f21d83a3f23 |
| PRODUCT NDC: | 0023-9177 |
| APPLICATION NUMBER: | NDA021262 |
Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers:
